<P> A serotonin -- norepinephrine -- dopamine reuptake inhibitor ( SNDRI ) , also known as a triple reuptake inhibitor ( TRI ) , is a type of drug that acts as a combined reuptake inhibitor of the monoamine neurotransmitters serotonin , norepinephrine , and dopamine . It does this by concomitantly inhibiting the serotonin transporter ( SERT ) , norepinephrine transporter ( NET ) , and dopamine transporter ( DAT ) , respectively . Inhibition of the reuptake of these neurotransmitters increases their extracellular concentrations and , therefore , results in an increase in serotonergic , adrenergic , and dopaminergic neurotransmission . </P>
<P> A serotonin -- norepinephrine -- dopamine reuptake inhibitor ( SNDRI ) , also known as a triple reuptake inhibitor ( TRI ) , is a type of drug that acts as a combined reuptake inhibitor of the monoamine neurotransmitters serotonin , norepinephrine , and dopamine . It does this by concomitantly inhibiting the serotonin transporter ( SERT ) , norepinephrine transporter ( NET ) , and dopamine transporter ( DAT ) , respectively . Inhibition of the reuptake of these neurotransmitters increases their extracellular concentrations and , therefore , results in an increase in serotonergic , adrenergic , and dopaminergic neurotransmission . </P>
what drug prolongs the effects of dopamine norepinephrine and serotonin
what drug prolongs the effects of dopamine norepinephrine and serotonin
A serotonin -- norepinephrine -- dopamine reuptake inhibitor ( SNDRI ) , also known as a triple reuptake inhibitor ( TRI )
A serotonin -- norepinephrine -- dopamine reuptake inhibitor ( SNDRI ) , also known as a triple reuptake inhibitor ( TRI )